Added to YB: 2025-07-01
Pitch date: 2025-06-29
GMAB [bullish]
Genmab A/S
+35.82%
current return
Author Info
Scalper's Lounge has a background in mid-office roles and now shares stock ideas in their newsletter. Sign up for the newsletter.
Company Info
Genmab A/S, a biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
Market Cap
DKK 19.1B
Pitch Price
DKK 1.3K
Price Target
N/A
Dividend
N/A
EV/EBITDA
17.23
P/E
20.12
EV/Sales
6.12
Sector
Biotechnology
Category
value
Sunday Market Prep - Ideas for the week ahead: Genmab A/S
GMAB: Biotech focused on antibody therapeutics for cancer. Trading at 11x 2026E earnings with 25% of market cap in net cash. Patent cliff on blockbuster Darzalex starts 2029. Founder-led. Thesis: 1) increasing generalist interest short-term 2) CEO delivering long-term. Added ~2% position.
Read full article (1 min)